Soy-Based Therapeutic Baby Formulas: Testable Hypotheses Regarding the Pros and Cons.
Soy-based infant formulas have been consumed in the United States since 1909, and currently constitute a significant portion of the infant formula market. There are efforts underway to generate genetically modified soybeans that produce therapeutic agents of interest with the intent to deliver those agents in a soy-based infant formula platform. The threefold purpose of this review article is to first discuss the pros and cons of soy-based infant formulas, then present testable hypotheses to discern the suitability of a soy platform for drug delivery in babies, and finally start a discussion to inform public policy on this important area of infant nutrition.
Department of Neurology, University of Wisconsin , Madison, WI , USA.
Cara J
CJ
Westmark
genetically modified; glyphosate; necrotizing enterocolitis; phytoestrogens; seizures; soy-based infant formula